Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=161 Randomized Supportive Care

A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists

Acute Myeloid Leukemia

Bottom Line

View on ClinicalTrials.gov: NCT05335369 ↗
Enrolled (actual)
161
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Shared Decision Making — 85.98; 86.55 Score on a Scale — p=0.85

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
UR-GOAL (Behavioral)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
University of Rochester
Primary completion
Apr 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Shared Decision Making		 85.98; 86.55 0.85
SECONDARY
Patient-Centered Communication in Cancer Care (PCC-Ca-36)		 4.20; 4.31; 4.43; 4.49; 4.45; 4.58 0.44

Summary

The objective of this study is to evaluate the preliminary efficacy of the UR-GOAL tool in improving shared decision making and communication between older patients with AML and their oncologists in a pilot randomized trial.

Eligibility Criteria

Inclusion Criteria

Patients

  • Age ≥60 years
  • Newly diagnosed AML or being worked up for possible AML
  • Able to provide informed consent
  • Agreement of their oncologist to participate in the study
  • English-speaking

If patients screen positive for cognitive impairment on the Mini-Cog test performed as part of the baseline assessment, they can still enroll if they are able to provide informed consent and have decision making capacity as determined by their treating oncologist

Caregivers

  • Selected by the patient when asked if there is a "family member, partner, friend or caregiver [age 21 or older] with whom the patient discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient
  • Able to provide informed consent
  • English-speaking

Oncologists

  • A practicing oncologist
  • At least one of their patients are recruited to the study
  • English-speaking
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05335369). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search